Solid Biosciences Inc. Ratios

Ratios Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -530.03%-1,282.88%22,070.45%35,470.29%
EBIT Margin -530.50%-1,315.20%23,693.64%38,155.29%
EBITDA Margin -530.50%-1,315.20%23,693.64%38,155.29%
Operating Margin -530.50%-1,315.20%23,693.64%38,155.29%
Net Margin -530.03%-1,282.88%22,070.45%35,470.29%
FCF Margin -580.36%-1,247.74%21,748.86%29,607.65%
Efficiency
Assets Average 107.89M121.53M137.32M201.77M246.32M212.60M
Equity Average 32.96M102.62M106.07M170.15M209.94M169.07M
Invested Capital -59.26M125.18M80.05M132.09M208.21M211.67M126.48M
Asset Utilization Ratio 0.070.030.00
Leverage & Solvency
Interest Coverage Ratio -236.94-381.55
Equity Ratio -0.780.900.770.770.900.810.77
Times Interest Earned -236.94-381.55
Valuation
Enterprise Value 63.81M-69.09M827.13M121.12M303.46M-14.76M-173.18M0.25M159.82M
Market Capitalization 949.59M204.64M458.21M193.02M40.54M123.89M159.82M
Return Ratios
Return on Sales -5.30%-12.83%220.70%354.70%
Return on Capital Employed -0.79%-1.16%-0.78%-0.41%-0.48%-0.53%
Return on Assets -0.70%-0.97%-0.64%-0.36%-0.42%-0.46%
Return on Equity -2.28%-1.15%-0.83%-0.42%-0.49%-0.57%